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NKp46 is a cell surface receptor expressed on natural killer (NK) cells, on a minute subset of T cells, and on a population of innate lymphoid cells that produce IL-22 and express the transcription factor retinoid-related orphan receptor (ROR) natural killer cell differentiation | NKp46 knock-in N atural killer (NK) cells are effector and regulatory lymphocytes of the innate immune system that contribute to tumor surveillance, hematopoietic allograft rejection, control of microbial infections, and pregnancy (1) . NK cells can be cytotoxic and secrete an array of cytokines and chemokines, such as IFN-γ and β-chemokines.
NKp46 (NCR1, CD335) is a marker of NK cells in all mammalian species tested so far, including human, nonhuman primates, mouse, rat, and cow (2) (3) (4) (5) (6) (7) (8) . NKp46 is an Ig-like superfamily cell surface receptor, which is a member of a group of natural cytotoxicity receptors (NCRs) with NKp44 (NCR2, CD336) and NKp30 (NCR3, CD337) (9) . NKp46 is associated with immunoreceptor tyrosine-based activation motif-bearing polypeptides, such as CD3-ζ and FcR-γ, which transduce potent activating signals upon triggering (4, 10) . NKp46 is involved in tumor cell recognition via still-unidentified ligands (11, 12) and has also been described as binding viral hemagglutinins (13, 14) . Finally, it has been reported that NK cells contribute via NKp46 to type I diabetes through the destruction of pancreatic β-islets (15) . NKp46 is found on all mature NK cells regardless of their anatomic localization in both human and mouse. The selective expression of NKp46 on NK cells has two reported exceptions: rare T-cell subsets (6, 16, 17) and a mucosal population of NKp46 + innate lymphoid cells (ILCs) that express the transcription factor retinoid-related orphan receptor (ROR)-γt and produce IL-22, a key cytokine for the activation and defense of epithelial cells (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) .
The NKp46 amino acid sequence is highly conserved in all mammals. The striking homologies in the regulatory regions of the NKP46 gene from opossum to human prompted us to generate a transgenic mouse line, called NDE, in which the diphtheria toxin receptor (DTR) and the enhanced green fluorescent protein (eGFP) expression were driven by a 450-bp conserved promoter region (P1) upstream of Nkp46 (Ncr1) start codon (6) . Although the selectivity of expression of eGFP in NDE mice mirrored that of endogenous NKp46 in a fraction of transgenic mice, variegation at the transgenic locus led to unpredictable variation in the penetrance of the transgene expression in mouse littermates. Another transgenic mouse expressing the improved Cre (iCre) recombinase under the control of the Nkp46 promoter was recently reported and crossed to eGFP reporter mice (29) . However, on average only 80% of NKp46 + NK cells expressed eGFP, and no eGFP expression was detected in T cells, suggesting that the regulation of the iCre transgene expression in this model did not match with the endogenous expression of NKp46, hence hampering the use of these mice for selective gene targeting in NKp46 + cells. To circumvent these caveats of expression pattern that are classically observed in transgenic mice (30), we generated a knock-in mouse line in which the gene encoded the improved recombinase (icre) was inserted by homologous recombination at the 3′ end of Nkp46, in an attempt to drive its expression by all endogenous Nkp46 regulatory elements. Here we report that iCre expression faithfully corresponds to the endogenous expression of NKp46, on bona fide NK cells, on a subset of gut ILCs, as well as on very discrete subpopulations of T cells, allowing us to trace the fate of the heterogeneous NKp46
+ populations of cells.
Results

Characterization of Nkp46
iCre Knock-in Mice. We generated a knockin mouse line in which icre was inserted by homologous recombination at the 3′ end of the Nkp46 gene ( Fig. 1A and Fig. S1 ).
Nkp46
iCre/wt mice were obtained at Mendelian frequencies, developed normally, were fertile, and showed no significant variations in the numbers of lymphoid and myeloid subsets compared with wild-type (wt) littermates. NK cell counts, phenotype, and in vitro effector function were not affected in Nkp46 iCre/wt mice, despite a down-regulation in the density of cell surface NKp46 that did not alter the percentage of NKp46 + NK cells (Fig. S2) 
CD3
− splenic cells matched with the expression of YFP expression (Fig. 1B) . NK cells isolated from bone marrow (BM), peripheral blood, spleen, parietal lymph nodes (LNs), mesenteric LNs, lungs, and thymus uniformly expressed eYFP (Fig. 1C) . Besides NK cells, discrete subsets of CD4 − CD8 − NK1.1 + T cells also express NKp46 (6, 16, 17) . Consistent with these data, minute percentages of eYPF + αβT and γδT cells were detected in the spleen (Fig. S3) . Reciprocally, splenic NKp46
− cells, such as B cells, CD4 and CD8 αβT cells, CD1d-restricted NKT cells, dendritic cells, neutrophils, and macrophages did not express eYFP (Fig. 1D) 
R26R
eYFP mice.
Expression of NKp46 During NK Cell Differentiation. It has been proposed that NK cell differentiation is initiated at a precursor stage (stage I) defined by the cell surface expression of CD122, the β-chain of IL-2/IL-15 receptors, and the lack of the lineage (lin) markers (33) . The acquisition of surface NK1.1 was used to define stage II of NK cell differentiation. Stage III NK cells was defined by the expression of c-kit (the stem cell factor receptor CD117), stage IV by the CD49 β1 integrin DX5, and stage V by the CD11b β2 integrin (34). On fully mature NK cells (stage V), c-kit and CD27 expression are lost, whereas KLRG-1 and CD43 are expressed (35) . One of the caveats of this classification resides in the use of mouse markers that are not conserved in human (e.g., DX5). In contrast to these molecules, NKp46 is conserved across species (7). We took advantage of the Nkp46 (Fig. S5) . Thus, the cell surface expression of NKp46 was acquired on BM NK cells after NK1.1. The monitoring of NK cell maturation using CD27 and CD11b markers further supported this kinetics of differentiation (36, 37) , because the acquisition of NKp46 occurred at the CD27 +
CD11b
−/low stage and remained stable ( Fig. 3C and Fig. S6 ). Similar data were obtained when NK cells were isolated from spleen, LNs, and lung.
Following the same track, we then focused on CD16 (FcγRIIIA). Indeed, the cell surface expression of CD16 defines a checkpoint in human NK cell differentiation that is associated with NK cell maturation, as evidenced by the perforin-dependent cytotoxic function of CD16 dim NK cells (39) . Although mouse NK cells also express CD16, the kinetics of CD16 surface expression on mouse NK cells is still unknown, in part due to the lack of reagent able to discriminate CD16 from CD32 (FcγRIIB). We addressed this issue using a recently described anti-CD16 antibody (40) . As shown in We then analyzed the kinetics of induction of CD94, NKG2D, DX5, CD11b, c-Kit, and Ly49 receptors (using a pan Ly49 mAb). We found that CD94 was expressed very early in CD122 + NK1.1 − cells (Fig. 4B ). Because the majority of NKG2D
−/low cells expressed CD16, the data indicated that CD16 induction preceded that of NKG2D (Fig. 4C) + cells in various organs by comparing for the expression of eYFP and the cell surface of NKp46. In BM, spleen, LNs, and lungs, NKp46 and eYFP were coexpressed (Fig. S9A Upper) . Less than 10% of splenic and BM eYFP + lymphocytes expressed low surface density of NKp46, but they did not correspond to a population of eYFP +
NKp46
− cells because they appeared as a continuum with NKp46 + cells (Fig.  S9A Upper) and were uniformly NK1.1 + (Fig. S9A Lower) . Confirmation of this interpretation was obtained by using a brighter revelation of the NKp46 fluorescence using an anti-NKp46 goat antiserum and Alexa 647-conjugated secondary reagent instead of an anti-NKp46 mAb (Fig. S10) . 
R26R
eYFP mice stained with anti-eYFP (green) and anti-RORt (red). Nuclei were counterstained with Sytox (grey). Scale bars, 10 mm. Data are representative of at least three experiments. 
A revised model of NK cell maturation is proposed based on the sequential expression of CD122, NK1.1, NKp46, CD16, and CD11b at NK cell surface.
A distinct picture emerged from the analysis of gut lymphocytes because two populations of cells expressing eYFP were detected in the small intestine (Fig. 5A Left) (Fig. 5B) and their ability to produce IL-22 at steady state and upon IL-23 stimulation (Fig.  S11) . In contrast, only the eYFP + NK1.1 + cells produced IFN-γ upon IL-12 and -18 stimulation, consistent with their bona fide small intestine NK cell identity (Fig. S11) .
Because the expression of iCre induced the irreversible expression of eYFP in Nkp46 iCre R26R eYFP mice, the distinct levels of eYFP observed at a single cell level could not result from a distinct regulation at the Nkp46 locus but, rather, indicated a distinct regulation of the Rosa26 locus in eYFP hi vs. eYFP + cells, as shown in other reporter mouse models (42 −/dim cells within the eYFP hi NK cell subset. This sign of immaturity in a subset of liver NK cells has been reported and associated with the low surface expression of DX5 and the constitutive expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) (45) . A similar phenotype was observed for the eYFP hi liver NK cells (Fig. 6 ), indicating that they corresponded to the CD11b
+ NK cell subset previously described in the same organ. The cell surface expression of Ly49 molecules was mostly restricted to the eYFP + liver NK cells as in the spleen (Fig.  S12B) , which is consistent with the bona fide NK cell phenotype of eYFP + liver NK cells and the more immature phenotype of eYFP hi liver NK cells. Genetic tracing revealed that these two liver subsets are quite divergent, because the level of eYFP expression in CD11b −/low and CD11b + BM NK cells was similar, in contrast to the distinct eYFP levels in CD11b −/low and CD11b + liver NK cells (Fig. S13) . Thus, the levels of YFP are not merely associated with various stages of NK cell maturation, but with a more profound lineage commitment of NK cell subsets, highlighting the use of Nkp46 iCre
eYFP mice for in vivo fate-mapping experiments.
Conclusions
We report here the fate mapping of NKp46 + cells in vivo through the generation and characterization of an unprecedented model of Nkp46 iCre knock-in mice. Earlier attempts to create a mouse model selectively targeting NKp46 + cells by using nontargeted transgenesis have failed due to a complex and still poorly understood regulation of the NKp46 locus (6, 29) . To visualize iCre activity in Nkp46 iCre mice, we crossed them with R26R eYFP reporter mice. In Nkp46 iCre
R26R
eYFP mice, the fluorescent reporter permanently labeled cells that had switched on the expression of the NKp46 gene. Using these mice, we have shown that the expression of iCre faithfully corresponded to the endogenous expression of NKp46. The genetic tracing of NKp46 + cells in vivo allowed us to reveal the stability of NKp46 cell surface expression. In addition, the acquisition of NKp46 marked a checkpoint of NK cell maturation. Based on these data, we propose a unique model of NK cell differentiation, which also includes CD16 as a marker of NK cell maturation. One advantage of this unique model resides in the use of cell surface molecules that are conserved in both mouse and human, with the exception of mouse NK1.1. Along this line, preliminary data obtained on CD34 + hematopoietic cell progenitors from human cord blood indicate that the induction of surface CD56 precedes that of NKp46 in an in vitro NK cell differentiation assay, supporting the hypothesis that CD56 could be positioned in the human NK cell differentiation pathway as NK1.1 in the mouse.
Furthermore, the differential expression of YFP in Nkp46 . Six-to eight-week-old offspring mice were used for experiments. Unnicked Diphtheria Toxin from Corynebacterium diphtheria (Calbiochem, 500 ng/mouse) diluted in PBS was injected i.p.
Cell Preparation. Cells were prepared as described (22) . For details, see SI Materials and Methods.
Flow Cytometry. Flow cytometric analysis was done on a FACS Canto (Becton Dickinson, San Diego, CA). For details on reagents, see SI Materials and Methods.
Tissue Immunofluorescence. Portions of small and large intestine were isolated from mice and treated as previously described (22) . For staining details, see SI Materials and Methods.
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SI Materials and Methods
Cell Preparation. Mice were anesthetized and immediately perfused with PBS before organs were collected. Spleens, thymus, and LNs were removed, triturated in RPMI 5% FCS at 4°C and then passed through a 100-μm cell strainer (BD). Bone marrow cell suspensions were obtained by flushing femurs and tibias. Red blood cells were then lysed with ACK buffer (NH 4 Cl, KHCO 3 , EDTA.Na 2 -2H 2 O, pH7.4). Livers and lungs were cut in small pieces and incubated at 37°C for 20 min in HBSS medium (Invitrogen) containing 4,000 U/ml collagenase I (Invitrogen). Samples were then enriched for lymphocytes by Percoll gradient centrifugation (Amersham-Pharmacia). Blood lymphocytes were enriched by Lympholyte Mammals centrifugation (Tebu-Cerdalane). Cells from small intestine were prepared as described (1).
Flow Cytometry. All mAbs were from PharMingen except the antiLy49D and H (eBioscience) and Ly49A and IL-18Rα (Biolegend). The anti-CXCR3, anti-CXCR6, the rat monoclonal anti-mouse FcγRIIIA/CD16, the goat anti-mouse NKp46 serum and control serum were purchased from R&D Systems. Anti-CD16 mAbs were revealed with a goat anti-rat IgG coupled to Alexa-647 and antiNKp46 polyserum was revealed with a donkey anti-goat Alexa-647 (Molecular Probes Fig. S1 . Generation of NKp46 iCre knock-in mice. (A) Schematic representation of the strategy used to generate NKp46 iCre mice. A 6.6 Kb fragment of the BAC clone no. RP23-106A10 (Imagenes) containing the entire exon 7 of Nkp46 and centered on the stop codon was inserted in the plasmid PACYC177 and flanked with SalI sites using Red/ET recombination (Gene Bridges). In brief, the following primers containing 85-bp homology with Nkp46 were used to amplify PA-CYC177 replication origin and ampicillin resistance gene: 5′-aatatgattagaatattgtatgcaattctcaattaataaaaatttaaaaaaatgaagctagtccacacaagtgttttcaattgcagtcgacgcgctagcggagtgtatactggc-3′ and 5′-aataagaaaagcagctgatagagtaagctaattgagtctttcagtccaatgccagatctctttagcattttgtgatactatgtcgactgaagacgaaagggcctcgtg-3′. The PCR product was electroporated into competent DH5α bacteria containing a plasmid encoding for phage recombinase and the BAC. Recombination events were screened by ampicillin resistance and PCR. The resultant plasmid was further subcloned by PCR with primers containing XhoI restriction sites (forward: ccgctcgagagctagttagaccagcaccatt; reverse: ccgctcgagaattgggggcttgttcacag). PacI and EcoRI restriction sites were inserted in the BglII restriction site located 30 bp downstream of the Nkp46 stop codon by ds-oligonucleotine cloning (forward: gatctttaattaacctagggcggccgcgatatc; reverse: gatcgatatcgcggccgccctaggttaattaaa). The IRES-iCre-Neomycin resistance cassette was subsequently inserted by PacI/EcoRI cloning. The XhoI fragment was used to insert the cassette in the plasmid containing Nkp46 6.6 kb fragment by Red/ET cloning. BRUCE 4 C57BL/6 ES cells were transfected with the SalI linearized targeting construct. After selection in G418, ES clones were selected by Southern blot using BamHI restriction enzyme digestion and probes amplified by the following primers: 5′ probe forward: gcaccttctgcagtcattca; 5′ probe reverse: ggcctcgcaactgttctcta; Neo R probe forward: gcgataccgtaaagcacgagg; Neo R probe reverse: gggaagggactggctgctattg; 3′ probe forward: aataagaaaagcagctgatagagtaag; 3′ probe reverse: ctgctctcttccatgttggtt. (B) Southern blot analysis of indicated ES clones using the 5′, 3′, and Neo probes; lower band derived from original locus and upper band derived from targeted locus. Gated on CD122 + NK1.1 + lin -BM cells 
